GUIDELINES ON SIMILAR BIOLOGICS

GUIDELINES ON RECALL AND RAPID ALERT SYSTEM …

Page 3 of 13 5.0 Recall Classification: Recall classification is a numerical designation, I, II, or III, that is assigned to a particular product recall that indicates the relative degree of health hazard by country

  Recall

Annexure-1 GMP CHECKLIST

SOP No.: EP-INS-004 Page 1 Annexure-1 GMP CHECKLIST (Based on WHO Good Manufacturing Practices (GMP) for active pharmaceutical ingredients stated as per

  Good, Practices, Pharmaceutical, Annexure 1 gmp checklist, Annexure, Checklist

INVESTIGATIONAL MEDICINAL PRODUCT …

C:\Users\website\Desktop\pendency july\IMPD Template Quality.doc Last printed 8/18/2016 8:02:00 PM INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER FOR

  Product, Dossiers, Medicinal, Investigational, Investigational medicinal product, Investigational medicinal product dossier for

LIST OF NEW DRUGS APPROVED IN INDIA FROM …

LIST OF NEW DRUGS APPROVED IN INDIA FROM 1991 TO 2000 S. No Name of Drug Pharmacological action/ Indication Date of Approval 1 Ciprofloxacin 0.3% w/v Eye

  Form, Drug, Lists, India, Approved, List of new drugs approved in india from

List of NABL Accredited Laboratories in India

Sr. No. Name of the Laboratory Nature of Lab Field Discipline Group Address Contact Details Organization Type 1 Alcatec Research Laboratories India Pvt.

(Medical Devices Division) - Central Drugs …

GUIDANCE DOCUMENT ON COMMON SUBMISSION FORMAT FOR IMPORT LICENSE OF NOTIFIED MEDICAL DEVICES. Page | 1 Guidance Document (Medical Devices Division)

  Devices, Medical, Drug, Division, Central, Medical device, Medical devices division, Central drugs

(Medical Devices and Diagnostic Division)

Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India

  Devices, Standards, Medical, Drug, Division, Central, Medical device, Central drugs standard

Manufacturing and Marketing permission issued …

S.No. Drug Name Indication Date of Approval 10 Everolimus tablets 2.5mg. 5mg and 10mg “Treatments of adults patients with progressive, well differentiated, non- ...

  Manufacturing, Marketing, Issued, Permission, Manufacturing and marketing permission issued

LIST OF LICENSED BLOOD BANKS IN INDIA * …

LIST OF LICENSED BLOOD BANKS IN INDIA * (February, 2015) Sr. No. State Total No. of Blood Banks 1. Andaman and Nicobar Islands 03 2. Andhra Pradesh 140 3.

  Bank, Blood, February, India, Licensed, Licensed blood banks in india

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics lactating women may be considered after careful evaluation of the benefits and risks in case of a medical emergency or an epidemic.

  Product, Summary, Characteristics, Summary of product characteristics

REPORT - Biotechnology by Amgen

3. WHAT ARE BIOLOGICS AND BIOSIMILARS? A biologic medicine is a large molecule derived from living cells that is used to treat or prevent disease, such as a therapeutic protein, DNA vaccine, monoclonal antibody (i.e., MAB) or fusion

  Report, Biologics

Guidelines on Similar Biologic: Regulatory …

Guidelines on Similar Biologic: Regulatory Requirements for Marketing Authorization in India _____ 11.

  Guidelines, Requirements, Regulatory, Marketing, Authorization, Biologics, Similar, Regulatory requirements for marketing authorization, Guidelines on similar biologics, Guidelines on similar

GUIDELINES ON EVALUATION OF SIMILAR ... - …

english only final expert committee on biological standardization geneva, 19 to 23 october 2009 guidelines on evaluation of similar biotherapeutic products (sbps)

  Guidelines, Similar